Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the 'resistant' Brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 40-49

  Stefferl, Andreas ^a   Brehm, Uschi ^a   Storch, Maria ^b   Lambracht Washington, Doris ^c   Bourquin, Carole ^a   Wonigeit, Kurt ^c   Lassmann, Hans ^b   Linington, Christopher ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DEMYELINATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EOSINOPHIL; GENE LOCUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANIMALS, CONGENIC; ANTIGENS, SURFACE; AUTOANTIBODIES; B-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HAPLOTYPES; IMMUNITY, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGODENDROGLIA; RATS; RATS, INBRED BN; RATS, INBRED LEW; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 0033168629     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Williams, R. M., and M. J. Moore. 1973. Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J. Exp. Med. 138:775.
2. Martin, R., H. F. McFarland, and D. E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.
3. Gasser, D. L., C. M. Newlin, J. Palm, and N. K. Gonatas. 1973. Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 181: 872.
4. Happ, M. P., P. Wettstein, B. Dietzschold, and E. Heber-Katz. 1988. Genetic control of the development of experimental allergic encephalomyelitis in rats: separation of MHC and non-MHC gene effects. J. Immunol. 141:1489.
5. Oksenberg, J. R., E. Seboun, and S. L. Hauser. 1996. Genetics of demyelinating diseases. Brain Pathol. 6:289.
6. Schmidt, D., J. Verdaguer, N. Averill, and P. Santamaria. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059.
7. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:2271.
8. Gay, D., and M. Esiri. 1991. Blood-brain barrier damage in acute multiple sclerosis plaques: an immunocytological study. Brain 114:557.
9. Storch, M. K., S. J. Piddlesden, M. Haltia, M. Iivanainen, P. Morgan, H. Lassmann, and S. Piddlesden. 1998. Multiple sclerosis: in situ Evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43:465.
10. Prineas, J. W. 1985. The neuropathology of multiple sclerosis. In Handbook of Clinical Neurology. J. Koetsier, ed. Elsevier Science, New York, p. 337.
11. Prineas, J. W., and J. S. Graham. 1981. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann. Neurol. 10:149.
12. Scolding, N. J., B. P. Morgan, W. A. Houston, C. Linington, A. K. Campbell, and D. A. Compston. 1989. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 339:620.
13. Adelmann, M., J. Wood, I. Benzel, P. Fiori, H. Lassmann, J. M. Matthieu, M. V. Gardinier, K. Dornmair, and C. Linington. 1995. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63:17.
14. Genain, C. P., M. H. Nguyen, N. L. Letvin, R. Pearl, R. L. Davis, M. Adelmann, M. B. Lees, C. Linington, and S. L. Hauser. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:2966.
15. Johns, T. G., N. Kerlero de Rosbo, K. K. Menon, S. Abo, M. F. Gonzales, and C. C. Bernard. 1995. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:5536.
16. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H. C. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
17. Cremer, M. A., M. M. Griffiths, K. Terato, and A. H. Kang. 1995. Type XI and II collagen-induced arthritis in rats: characterization of inbred strains of rats for arthritis- susceptibility and immune-responsiveness to type XI and II collagen. Autoimmunity 20:153.
18. Linington, C., A. Mann, S. Izumo, K. Uyemura, M. Suzuki, R. Meyermann, and H. Wekerle. 1986. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease. J. Immunol. 137:3826.
19. Hoedemaekers, A. C., J. J. Verschuuren, F. Spaans, Y. F. Graus, S. Riemersma, P. J. van Breda Vriesman, and M. H. De Baets. 1997. Age-related susceptibility to experimental autoimmune myasthenia gravis: immunological and electrophysiological aspects. Muscle Nerve 20:1091.
20. Saoudi, A., M. Castedo, D. Nochy, C. Mandet, R. Pasquier, P. Druet, and L. Pelletier. 1995. Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients. Eur. J. Immunol. 25:1972.
21. Lambracht, D., H. J. Hedrich, and K. Wonigeit. 1993. Deletion of major histocompatibility complex class I genes in a new mutant RT1 haptotype (lm3) defined in BN. 1LM3/Han rats. Transplant. Proc. 25:2756.
22. Lambracht, D., C. Prokop, H. J. Hedrich, K. Fischer Lindahl, and K. Wonigeit. 1995. Mapping of H2-M homolog and MOG genes in the rat MHC. Immunogenetics 42:418.
23. Durand, D. B., M. Kamoun, C. A. Norris, N. J. Holbrook, J. S. Greengard, G. R. Crabtree, and J. A. Kant. 1986. Retroviral activation of interleukin 2 gene in a gibbon ape T cell lymphoma line. J. Exp. Med. 164:1723.
24. Piddlesden, S. J., M. K. Storch, M. Hibbs, A. M. Freeman, H. Lassmann, and B. P. Morgan. 1994. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152:5477.
25. Vass, K., H. Lassmann, H. Wekerle, and H. M. Wisniewski. 1986. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol. 70:149.
26. Khoruts, A., S. D. Miller, and M. K. Jenkins. 1995. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 155:5011.
27. Linington, C., B. Engelhardt, G. Kapocs, and H. Lassmann. 1992. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol. 40:219.
28. Pham-Dinh, D., M. G. Mattei, J. L. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I. H. Mather, K. Artzt, K. F. Lindahl, and A. Dautigny. 1993. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompalibility complex. Proc. Natl. Acad. Sci. USA 90:7990.
29. Pham-Dinh, D., E. P. Jones, G. Pitiot, B. Della Gaspera, P. Daubas, J. Mallet, D. Le Paslier, K. Fischer Lindahl, and A. Dautigny. 1995. Physical mapping of the human and mouse MOG gene at the distal end of the MHC class Ib region. Immunogenetics 42:386.
30. Chung, I. Y., J. G. Norris, and E. N. Benveniste. 1991. Differential tumor necrosis factor a expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J. Exp. Med. 173:801.
31. Peers, S. H., G. S. Duncan, R. J. Flower, and C. Bolton. 1995. Endogenous corticosteroids modulate lymphoproliferation and susceptibility to experimental allergic encephalomyelitis in the Brown Norway rat. Int. Arch. Allergy Immunol. 106:20.
32. Levine, S., and A. Saltzman. 1988. The role of antigen absorption in the resistance of brown-Norway rats to experimental allergic encephalomyelitis. Immunol. Lett. 19:103.
33. Massa, P. T., V. ter Meulen, and A. Fontana. 1987. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 84:4219.
34. 2-induced down-modulation of the disease. Eur. J. Immunol. 18:243.
35. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34.
36. Gladue, R. P., L. A. Carroll, A. J. Milici, D. N. Scampoli, H. A. Stukenbrok, E. R. Pettipher, E. D. Salter, L. Contillo, and H. J. Showell. 1996. Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J. Exp. Med. 183:1893.
37. Lafaille, I. J., F. V. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
38. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449.
39. Dent, L. A., M. Strath, A. L. Mellor, and C. J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172:1425.
40. Lassmann, H., C. Brunner, M. Bradl, and C. Linington. 1988. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating Abs determines size and structure of demyelinated lesions. Acta Neuropathol. 75:566.
41. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal Abs directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443.
42. Matsumoto, Y., K. Kawai, Y. Tomita, and M. Fujiwara. 1990. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats: implication for susceptibility to autoimmune encephalomyelitis. Immunology 69:215.
43. Levine, S., and R. Sowinski. 1975. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J. Immunol. 114:597.
44. Höllerhage, H. G., G. F. Walter, and D. Stolke. 1989. Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model. Acta Neuropathol. 77:307.
45. Linington, C., B. P. Morgan, N. J. Scolding, P. Wilkins, S. J. Piddlesden, and D. A. Compston. 1989. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112:895.
46. Kerlero de Rosbo, N. , P. Honegger, H. Lassmann, and J. M. Matthieu. 1990. Demyelination induced in aggregating brain cell cultures by a monoclonal Ab against myelin/oligodendrocyte glycoprotein. J. Neurochem. 55:583.
47. Dietzschold, B., W. Schwaeble, M. K. Schafer, D. C. Hooper, Y. M. Zehng, F. Petry, H. Sheng, T. Fink, M. Loos, H. Koprowski, et al. 1995. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J. Neurol. Sci. 130:11.
48. Abadie, A., and A. Prouvost-Danon. 1980. Specific and total IgE responses to antigenic stimuli in Brown-Norway. Lewis and Sprague-Dawley rats. Immunology 39:561.
49. Peers, S. H., G. S. Duncan, and R J. Flower. 1993. Development of specific Ab and in vivo response to antigen in different rat strains: effect of dexamethasone and importance of endogenous corticosleroids. Agents Actions 39:174.
50. McFarlin, D. E., S. C. Hsu, S. B. Slemenda, C. H. Chou, and R. F. Kibler. 1975. The immune response against an encephalitogenic fragment of guinea pig basic protein in the Lewis and Brown Norway strains or rat. J. Immunol. 115:1456.
51. Weissert, R., E. Wallström, M. K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson. 1998. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102:1265.
52. Storch, M. K., A. Stefferl, U. Brehm, R. Weissert, E. Wallström, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681.
53. Genain, C. P., B. Cannella, S. L. Hauser, and C. S. Raine. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:170.